Although inflammation is a powerful driver of tumor growth,26 it is the aim of this review to focus on the connection between insulin/IGF-1 signaling and cancer, and discuss possibilities to modulate these interactions through DR and pharmaceutical interventions to improve cancer outcomes. The gene discussed is IGF1; the disease is neoplasm.